Serum factors inhibiting some leukocytic functions in Hodgkin's disease
- 1 April 1982
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 23 (1) , 124-132
- https://doi.org/10.1016/0090-1229(82)90077-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Serum migration-inhibitory activity in children with acute infectious mononucleosisClinical Immunology and Immunopathology, 1981
- Serum migration-inhibitory activity in patients with acute leukemia and early leukemic lymphosarcomaClinical Immunology and Immunopathology, 1979
- Leukocyte migration inhibitory activity in the serum of patients affected by Hodgkin's disease and other immunoproliferative diseasesPublished by Elsevier ,1978
- Serum-associated inhibition of leukotaxis in humans with cancerClinical Immunology and Immunopathology, 1978
- Serum migration inhibitory activity in patients with infectious diseases and various neoplasiaPublished by Elsevier ,1977
- Production of leukocyte inhibitory factor (LIF) in Hodgkin's diseaseClinical Immunology and Immunopathology, 1977
- Leukocyte migration inhibition by cancer patients' seraInternational Journal of Cancer, 1976
- LEUKOCYTE LOCOMOTION AND CHEMOTAXISThe Journal of Experimental Medicine, 1973
- A NEUTROPHIL-IMMOBILIZING FACTOR DERIVED FROM HUMAN LEUKOCYTESThe Journal of Experimental Medicine, 1972
- TUBERCULIN‐INDUCED MIGRATION INHIBITION OF HUMAN PERIPHERAL LEUCOCYTES IN AGAROSE MEDIUMAllergy, 1971